check_circleStudy Completed
Contraception
Bayer Identifier:
13760
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
Not Available
EU CT Number:
Not Available
International Active Surveillance Study of Women Taking Oral Contraceptives (INAS-OC)
Trial purpose
Primary objective(s):
• To assess the risks of short- and long-term use of DRSP24d and of established OCs in a study population that is representative for the actual users of the individual preparations.
• In a sub-analysis DRSP24d is compared to levonorgestrel-containing OCs.
Secondary objective(s):
• General safety, contraceptive effectiveness and the drug utilization pattern of DRSP24d, as well as the baseline risk for users of individual OC formulations.
• To assess the risks of short- and long-term use of DRSP24d and of established OCs in a study population that is representative for the actual users of the individual preparations.
• In a sub-analysis DRSP24d is compared to levonorgestrel-containing OCs.
Secondary objective(s):
• General safety, contraceptive effectiveness and the drug utilization pattern of DRSP24d, as well as the baseline risk for users of individual OC formulations.
Key Participants Requirements
Sex
FemaleAge
NaN - N/ATrial summary
Enrollment Goal
85109Trial Dates
August 2005 - February 2013Phase
N/ACould I Receive a placebo
N/AProducts
YAZ (EE20/DRSP, BAY86-5300)Accepts Healthy Volunteer
N/APrimary Outcome
- Risks of short- and long-term use of DRSP24d
- Risks of short- and long-term use of established OCs
- DRSP24d comparison to levonorgestrel-containing OCs
Secondary Outcome
- General safety, contraceptive effectiveness and the drug utilization pattern of DRSP24d, as well as the baseline risk for users of individual OC formulations
Trial design
Trial Type
ObservationalIntervention Type
N/ATrial Purpose
N/AAllocation
N/ABlinding
N/AAssignment
N/ATrial Arms
N/A